Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?
Crossref DOI link: https://doi.org/10.1007/s10238-017-0460-7
Published Online: 2017-04-08
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Roviello, Giandomenico
Zanotti, Laura
Cappelletti, Maria Rosa
Gobbi, Angela
Dester, Martina
Paganini, Giovanni
Pacifico, Chiara
Generali, Daniele
Roudi, Raheleh
License valid from 2017-04-08